Syndax Pharmaceuticals In... (SNDX)
15.65
0.01 (0.06%)
At close: Mar 03, 2025, 12:34 PM
Syndax Pharmaceuticals Income Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Revenue | n/a | n/a | 139.71M | 1.52M | 1.52M | 1.52M | 2.11M | 1.22M | 627K | n/a | n/a | n/a | n/a |
| Cost of Revenue | 12K | 454K | 456K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 51K |
| Gross Profit | -12K | -454K | 139.25M | 1.52M | 1.52M | 1.52M | 2.11M | 1.22M | 627K | n/a | n/a | n/a | -51K |
| Operating Income | -229.95M | -151.76M | 26.22M | -71.42M | -57.54M | -75.88M | -61.95M | -43.77M | -20.51M | -21.33M | -8.57M | -8.73M | -9.62M |
| Interest Income | 21.16M | 5.87M | 403K | 841K | 1.57M | n/a | n/a | n/a | 161K | n/a | n/a | n/a | n/a |
| Pretax Income | -209.36M | -149.34M | 24.93M | -73.16M | -56.05M | -73.96M | -60.8M | -44.47M | -24.12M | -19.83M | -14.17M | -9.96M | -13.09M |
| Net Income | -209.36M | -143.75M | 24.93M | -73.07M | -55.95M | -73.96M | -60.8M | -44.47M | -24.12M | -19.83M | -14.17M | -9.96M | -13.09M |
| Selling & General & Admin | 66.92M | 33.26M | 25.24M | 22.5M | 16.06M | 17.29M | 15.86M | 13.32M | 11.59M | 11.16M | 5.36M | 3.49M | 3.48M |
| Research & Development | 163.02M | 118.5M | 88.25M | 50.44M | 42.99M | 60.11M | 48.2M | 31.66M | 9.55M | 10.18M | 3.21M | 5.24M | 6.09M |
| Other Expenses | n/a | 2.42M | -1.29M | -1.74M | 1.49M | 1.92M | 1.15M | -706K | -37K | 4K | -3.01M | -1K | n/a |
| Operating Expenses | 229.95M | 151.76M | 113.49M | 72.94M | 59.06M | 77.39M | 64.06M | 44.99M | 21.14M | 21.33M | 8.57M | 8.73M | 9.57M |
| Interest Expense | 208K | 3.14M | 1.9M | 2.36M | 1.57M | 1.94M | 1.42M | 956K | 1.57M | n/a | n/a | n/a | 1.99M |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 229.95M | 151.76M | 113.49M | 72.94M | 59.06M | 77.39M | 64.06M | 44.99M | 21.14M | 21.33M | 8.57M | 8.73M | 9.62M |
| Income Tax | n/a | -5.59M | -43K | -89K | -92K | 1.92M | -76K | -89K | 1.54M | -1.5M | 2.59M | 1.23M | n/a |
| Shares Outstanding (Basic) | 70.26M | 60.76M | 52.06M | 41.31M | 30.49M | 25.37M | 21M | 14.62M | 17.37M | 9.6M | 8.01M | 70.28M | 619.96K |
| Shares Outstanding (Diluted) | 70.37M | 60.76M | 53.62M | 41.31M | 30.49M | 25.37M | 21M | 14.62M | 17.37M | 9.6M | 8.01M | 70.28M | 619.96K |
| EPS (Basic) | -2.98 | -2.37 | 0.48 | -1.77 | -1.84 | -2.92 | -2.9 | -3.04 | -1.39 | -2.07 | -1.77 | -0.14 | -21.11 |
| EPS (Diluted) | -2.98 | -2.37 | 0.46 | -1.77 | -1.84 | -2.92 | -2.9 | -3.04 | -1.39 | -2.07 | -1.77 | -0.14 | -21.11 |
| EBITDA | -229.94M | -151.76M | 27.28M | -70.29M | -55.6M | -73.88M | -61.88M | -43.68M | -20.49M | -21.32M | -8.56M | -5.26M | -11.05M |
| Depreciation & Amortization | 12K | 454K | 456K | 515K | 451K | 78K | 76K | 89K | 21K | 15K | 13K | 34K | 51K |